Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Coverage Of Post-Approval Studies Seeks To Improve Data For NCDs

This article was originally published in The Gray Sheet

Executive Summary

CMS' decision to pay for carotid artery stenting with embolic protection in post-approval studies advances the agency's interest in efficiently gathering data to better inform national coverage determinations

You may also be interested in...



Carotid Stenting In Asymptomatic Patients Feared By UK Vascular Surgeon

Favorable reimbursement policies for carotid stenting may lead to inappropriate applications of the procedure, particularly in asymptomatic patients, according to UK device safety panelist Peter Bell, MD, University of Leicester

Carotid Stenting In Asymptomatic Patients Feared By UK Vascular Surgeon

Favorable reimbursement policies for carotid stenting may lead to inappropriate applications of the procedure, particularly in asymptomatic patients, according to UK device safety panelist Peter Bell, MD, University of Leicester

Medicare Will Cover PET To Distinguish Alzheimer’s From Other Dementia

CMS' decision to provide national coverage of FDG-PET imaging for some suspected dementia patients corresponds with the Neuroimaging Work Group of the Alzheimer's Association's consensus position

Related Content

UsernamePublicRestriction

Register

LL1134478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel